Dr. JürgenBeninca

Partner

Frankfurt + 49.69.9726.3939

Dr. Jürgen Beninca counsels European and U.S. corporate clients on antitrust regulatory compliance and represents businesses before cartel authorities — including the German Federal Cartel Office and the European Commission — and before courts in antitrust matters. Antitrust follow-on litigation cases constitute an important part of his practice. In addition to antitrust, he assists clients in internal investigations and guides clients through the screening process of foreign direct investments into Germany under Germany's Foreign Trade and Payments Ordinance (AWV).

Jürgen's experience includes winning merger control approvals from the German Federal Cartel Office and the European Commission in a variety of industrial sectors, including the automotive, banking, nonwoven, pharmaceutical, and chemical industries. He also has been involved in various international, European, and national antitrust investigations in the banking, cement, automotive, insurance, and industrial minerals industries. His regulatory practice focuses on cartel and distribution cases and abuses of a dominant position. Jürgen's litigation experience includes the representation of two U.S. financial institutions in approximately 300 different cases.

He currently represents a sweets manufacturer in front of the German Federal Supreme Court in a case concerning the mere exchange of competitively sensitive information and is defending an automotive supplier against an antitrust damage claim brought by a car manufacturer. He also recently obtained a certificate of non-objection pursuant to Section 58 AWV for the acquisition of a German target by a Chinese client from the German government.

Experience

  • Riverside sells Bohemia Interactive Simulations to BAE SystemsJones Day is advising The Riverside Company in the sale of Bohemia Interactive Simulations (Bohemia) to BAE Systems, one of the world’s largest defense contractors.
  • The Duchossois Group sells The Chamberlain Group LLC to BlackstoneJones Day advised The Duchossois Group, Inc. in the sale of The Chamberlain Group LLC, a global leader in smart access solutions, to private equity funds managed by Blackstone.
  • Milliken & Company acquires Encapsys, LLCJones Day advised Milliken & Company in its acquisition of Encapsys, LLC, a world leader in microencapsulation delivery systems for the building, construction, paper, bedding and personal care industries.
  • ArchiMed acquires Cube Biotech GmbHJones Day advised ArchiMed, a leading Trans-Atlantic private equity healthcare specialist, on its acquisition of Cube Biotech GmbH, a leading provider of expression, purification, and crystallization services and products for membrane proteins.
  • American Industrial Partners subsidiary Vertex Aerospace announces acquisition of Raytheon Technologies' Defense Training and Mission Critical Solutions business linesJones Day is advising American Industrial Partners in the acquisition by portfolio company, Vertex Aerospace, of Raytheon Technologies' Defense Training, Professional Services, Mission Critical Solutions, and Modernization and Sustainment business lines.
  • Riverside and Investcorp sell Arrowhead Engineered Products to GenstarJones Day advised The Riverside Company in the sale of Arrowhead Engineered Products to Genstar.
  • Cardinal Health sells its Cordis business to Hellman & Friedman for approximately $1 billionJones Day advised Cardinal Health on the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • PTTGC acquires allnex from AdventJones Day is advising PTT Global Chemical Public Company Limited in the €4 billion acquisition of allnex Holding GmbH from Advent International.
  • EagleTree Capital sells Airtech Group, US Valve Corporation, and related entities to IDEX Corporation for $470 millionJones Day represented investment funds managed by EagleTree Capital in the sale of Airtech Group, US Valve Corporation, and related entities to IDEX Corporation for $470 million.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • Koch Equity Development acquires Transaction Network ServicesJones Day advised Koch Equity Development LLC, the acquisition and investment subsidiary of Koch Industries, Inc., in the acquisition of Transaction Network Services, Inc. (TNS) from affiliates of Siris Capital Group, LLC and TNS' other minority equity holders.
  • Verizon acquires incubed ITJones Day advised Verizon Communications, Inc. in its acquisition of incubed IT, the creator of a software platform providing autonomous navigation tools to administer, manage, and optimize mixed fleets of robots in industrial settings.
  • Milliken & Company acquires Zebra-chemJones Day advised Milliken & Company in its acquisition of Zebra-chem GmbH, a global chemicals company known for its peroxide and blowing agent masterbatches.
  • Solvay sells barium, strontium and sodium percarbonate businesses to Latour CapitalJones Day advised Solvay S.A., a publicly listed chemical company based in Brussels, Belgium, on the combined sale of its technical-grade barium and strontium business in Germany, Spain and Mexico, and its sodium percarbonate business in Germany to Latour Capital.
  • Verint Systems separates into two independent companiesJones Day advised Verint® Systems Inc. ("Verint") in the separation and spin-off of its cyber intelligence business, Cognyte Systems Ltd.
  • Astellas returns rights to Eligard® in Europe, Middle East, CIS, and Asia to TolmarJones Day represented Astellas Pharma Europe Ltd. in connection with a series of transactions, including the sale of related assets, in which Astellas returned its in-licensing rights to Eligard® (leuprorelin acetate for injectable suspension), a treatment for advanced prostate cancer, sold by Astellas in Europe, the Middle East, the Commonwealth of Independent States (CIS) and Asia, to Tolmar International Limited.
  • Sanofi sold Effortil (Etilefrin) pharmaceuticals products to SERB SAJones Day advised Sanofi in the sale of the Effortil (Etilefrin) pharmaceuticals products to SERB SA.
  • Astellas transfers DIFICLIR in Europe, Middle East, Africa, and selected CIS to Swiss Tillotts Pharma AG for €109 millionJones Day advised Astellas Pharma Europe Ltd. on the sale of distribution rights to the product "DIFICLIR" in Europe, Middle East, Africa, and selected Commonwealth of Independent States (CIS) countries to Swiss Tillotts Pharma AG for €109 million.
  • Materion acquires Optics Balzers, AG for $160 millionJones Day advised Materion Corporation, a global supplier of highly engineered advanced enabling materials, in its $160 million acquisition of Optics Balzers, AG, an industry leader in thin film optical coatings.
  • ebase GmbH to acquire securities business of Augsburger AktienbankJones Day is advising European Bank of Financial Services GmbH (ebase) in the acquisition of the securities business of Augsburger Aktienbank AG.
  • The following represents experience acquired prior to joining Jones Day.

    Represented a German moving services company in a parallel cartel investigation by the U.S. Department of Justice and the German Federal Cartel Office.

    Represented a leading Austrian bank in an investigation by the European Commission for price-fixing and in the appeal against the fine imposed by the Commission in the front of the European Courts in Luxemburg.

    Represented a leading manufacturer of brakes for rail and commercial vehicles in obtaining merger clearances from the European Commission, the German Federal Cartel Office, and other jurisdictions around the world in a variety of transactions involving highly concentrated markets.

    Represented acquisitions by private equity funds of a broad variety of businesses in obtaining merger clearance from the German Federal Cartel Office and in coordinating the filings in other jurisdictions.

    Represented two leading U.S. financial institutions in a series of lawsuits filed by German investors alleging tort claims involving kickbacks and churning.

    Successfully represented an insurance company in an antitrust investigation by the German Federal Cartel Office.

    Represented various providers of core banking systems and related services to Germany cooperative and savings banks in obtaining merger clearances from the German Federal Cartel Office.

    Represented a manufacturer of dry mortar in an antitrust investigation by the German Federal Cartel Office and in subsequent proceedings in front of the Düsseldorf Higher Regional Court and the German Federal Supreme Court.

    Successfully represented a dealer of bathroom equipment in an antitrust investigation by the German Federal Cartel Office.

    Represented a European stock exchange in the appeal against the blocking decision of the European Commission regarding the merger with a U.S.-based competitor in front of the European Court in Luxemburg.

    Speaking Engagements

    • November 26, 2021
      Umsetzung der EU-Richtlinie "Unfaire Handelspraktiken in der Lebensmittellieferkette" by ZLR and LebensmittelZeitung Transposition of the EU UTP Directive, Seminar by ZLR and LebensmittelZeitung
    • November 23, 2021
      BAFA at the gates of German companies? The German Corporate Due Diligence Act, Jones Day German Client Conference
    • September 22, 2021
      Supply Chain Act – Practical Steps for Implementing the New Legal Requirement
    • September 7, 2021
      Supply Chain Act - And Now? Legal Requirements and Their Implementation in Practice
    • October 30, 2020
      Foreign Direct Investment Screening Procedures - The New Normal? - Foreign Direct Investment Control in Germany
    • September 24, 2019
      Loan Market Association, Syndicated Loans Conference Impact of competition law and the EC study on the loan market
    • September 27, 2018
      Recent Developments in European and German FDI Control law, panelist, Canadian Bar Association Competition Law Fall Conference, Competition, Trade & National Security
    • June 14, 2018
      Arbeitstagung der Studienvereinigung Kartellrecht, Ist die „europäische Auslegung“ des § 1 GWB bzw. die Anwendung von Art. 101 AEUV durch deutsche Gerichte noch mit tragenden Verfahrensgrundsätzen des deutschen Ordnungswidrigkeitenrechts vereinbar?
    • March 2, 2018
      Working Group Day 2018 of the DAJV (German-American Lawyers’ Association)